Dr. Gregory A Jicha, MD, PhD
Claim this profileUniversity of Kentucky
Studies Alzheimer's Disease
Studies Dementia
7 reported clinical trials
10 drugs studied
Area of expertise
1Alzheimer's Disease
2Dementia
Aβ(1-42) positive
Total Tau positive
Phospho-tau negative
Affiliated Hospitals
Clinical Trials Gregory A Jicha, MD, PhD is currently running
CT1812
for Early Alzheimer's Disease
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.
Recruiting0 awards Phase 2
CBD + THC
for Agitation in Dementia
This is a multicenter randomized double-blind placebo-controlled Phase 2 study of an oral combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) compared to placebo over 12 weeks. This study is designed to test the hypothesis that treatment with an oral combination of THC/CBD will reduce agitation hospice care-eligible patients with agitation and dementia as measured by the Cohen Mansfield Agitation Inventory (CMAI) when compared to placebo at 2 weeks. This study will enroll approximately 150 participants of any gender at least 40 years of age who are hospice care-eligible with agitation and dementia (HAD). Participants will be randomized (50:50) to either active study drug (T2:C100) or placebo. The double-blind period of this study is 12 weeks. A 12 week optional open-label extension will be offered to participants who complete the double-blind period.
Recruiting0 awards Phase 215 criteria
More about Gregory A Jicha, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Gregory A Jicha, MD, PhD has experience with
- Placebo
- Nicorandil
- Placebo Oral Capsule
- Prazosin
- Simufilam
- Masupirdine
Breakdown of trials Gregory A Jicha, MD, PhD has run
Alzheimer's Disease
Dementia
Akathisia
Mild Cognitive Impairment
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory A Jicha, MD, PhD specialize in?
Gregory A Jicha, MD, PhD focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved treating patients, or patients who are undergoing treatment.
Is Gregory A Jicha, MD, PhD currently recruiting for clinical trials?
Yes, Gregory A Jicha, MD, PhD is currently recruiting for 3 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Gregory A Jicha, MD, PhD has studied deeply?
Yes, Gregory A Jicha, MD, PhD has studied treatments such as Placebo, Nicorandil, Placebo oral capsule.
What is the best way to schedule an appointment with Gregory A Jicha, MD, PhD?
Apply for one of the trials that Gregory A Jicha, MD, PhD is conducting.
What is the office address of Gregory A Jicha, MD, PhD?
The office of Gregory A Jicha, MD, PhD is located at: University of Kentucky, Lexington, Kentucky 40506 United States. This is the address for their practice at the University of Kentucky.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.